Immunopharm: Glucocorticoids, Calcineurn inhibitors, Proliferation Signal Inhibitors, inhibitors of Angiogenesis Flashcards
What are immunosupressive drugs used for?
Dampen the immune response in organ transplantation and auto-immune disease
The first immunosupressive agent are Glucocorticoids. What is their MOA?
Steroid Hormones
- -act by binding to the cytosolic glucocorticoid receptor
- -the glucocorticoid-glucocorticoid receptor complex translocates to the nucleus and binds to the glucocorticoid response elements in the promoter region of specific genes
The overall effect of glucocorticoid administration is anti-inflammatory and immunosupressive. What is the MOA for this?
Down regulate the expression of
–cytokines: TNFalpha, IL-1 and IL-4
Suppress eicosanoid biosynthesis
Glucocorticoids inhibit prostaglandin synthesis and therefore suppress inflammatory pathways. There are three mechanisms, each card will go through one. The first is induction of annexin I, explain this
Induce synthesis of annexin I
–anti-inflammatory protein that inhibits cytosolic phospholipase A2 (blocks the release of arachidonic acid)
The second mechanism for glucocorticoids is induction of MAPK phosphatase 1, explain
Induce MAPK phosphatase I
–dephosphorylates and inactivates MAPKs therefore inhibiting proinflammatory signaling pathways
The third mechanism for glucocorticoids is repression of transcription of cyclooxygenase 2, explain
NF-kB is a transcription fact that stimulates transcription of cytokines and chemokines as well as COX2
–glucocorticoids inhibit NF-kB therefore reducing COX2
What are adverse effects of glucocorticoids?
Short term administration: HTN, hyperglycemia, immunosuppression, psychotic reactions and cognitive impairment
Long term administration: osteoporosis, weight gain, fluid retention, cataracts, poor wound healing, gastric ulcers, GI bleeding, hyperglycemia, HTN, adrenal suppression and increased risk of infection
What are the uses of glucocorticoids?
Prevent and treat transplant rejection
–most commonly used are prednisone and methylprednisolone
Treat Autoimmune Disorders (RA, SLE and so on)
–prednisone and prednisolone
Alleviate symptoms such as pain, nausea, anorexia, and malaise and improve quality of life (palliative care)
Can be used for pain
–dexamethasone is preferred for cancer pain due to long half life
Next set of drugs are the calcineurin inhibitors. The first drug is cyclosporine. What is the primary use?
Organ transplant
Uveitis
RA
Psoriasis
What is the MOA of cyclosporine?
Binds to cyclophilin
–cyclosporine + cyclophilin complex that inhibits cytoplasmic phosphatase, calcineurin, which is needed to activate T cell specific transcription factor (NF-AT)
–NF-AT is involved in the synthesis of interleukins by activated T cells
Cyclosporines inhibit gene transcription of IL-2,IL-3, IFN-gamma and other factors produced by T cells
What are the adverse effects of cyclosporine?
Toxicities: nephro, tremor, HTN, hyperglycemia, hyperlipidemia, osteoporosis, hirsutism, gum hyperplasia
Nephrotoxicity is limiting and occurs in majority of patients treated
Little bone marrow toxicity
Metabolized by CYP3A4 (drug interactions)
Tacrolimus is the other calcineurin inhibitor. What is the MOA?
Binds to FK-binding protein (FKBP)
–this complex inhibits calcineurin which is needed for activation of T cell specific transcription factor NF-AT
What are adverse effects and uses of Tacrolimus?
Adverse effects:
—similar to that of cyclosporine: nephrotoxicity, neurotoxicity, hyperglycemia, HTN, hyperkalemia and GI complaints
Uses:
–prevention of rejection of transplanted kidneys, liver or heart
Next set of drugs are the proliferation signal inhibitors, first is Sirolimus, what is the MOA?
Binds to FK-BP
- -complex then binds to and inhibits serine-threonine kinase mTOR
- -blockage of mTOR blocks IL-2 driven T cell proliferation
What are adverse effects and uses of Sirolimus?
Adverse Effects:
–myelosuppression, hepatotoxicity, diarrhea, hypertrigylceridemia, pneumonitis, and headache
Uses:
—approved for use in renal transplantation
–used to inhibit restenosis of the blood vessels in patients with severe coronary artery disease by reducing cell proliferation